ABBV
AbbVie Inc.
NYSE
Healthcare
$216.24
+3.25
(+1.52%)
Updated: 3/31/2026, 4:00:01 PM
Open
$215.06
High
$219.06
Low
$213.03
Prev Close
$213.12
Volume
2.30M
Price History
Why Is ABBV ▲ Up Today?
+1.52%
Full AI analysis generates after market close. Showing live price data.
Mar 31
▲
+1.5%
AbbVie (ABBV) Climbs on Analyst Support and Aesthetics Momentum
Mar 30
▲
+1.8%
AbbVie (ABBV) Rises Amidst Positive Dividend News and Sector Gains
Mar 27
▼
-0.9%
ABBV dips slightly amid sector weakness, remains attractive for dividends
Mar 26
▲
+1.9%
AbbVie (ABBV) Rises on Positive Catalysts, Pipeline Developments
Mar 25
▲
+1.0%
ABBV Rises Slightly Amidst Positive Sentiment and Sector Underperformance
Mar 24
▲
+0.1%
AbbVie (ABBV) Up Slightly Amidst Mixed Sentiment
Mar 23
▼
-0.5%
ABBV Declines Amidst Sector Weakness and Competitive Pressures
Mar 20
▼
-0.6%
ABBV Declines Amidst Sector Weakness and Competitive Pressure
Mar 19
▼
-1.0%
ABBV down 1.00% as competition heats up in immunology
Mar 18
▼
-5.2%
AbbVie (ABBV) Slides Amidst Healthcare Sector Weakness
Mar 17
▼
-0.8%
ABBV Declines Slightly Amid Sector Weakness
Mar 16
▲
+0.7%
AbbVie (ABBV) Up Slightly on Positive Obesity Drug Data
Mar 13
▼
-2.5%
AbbVie (ABBV) Drops Amidst Mixed Signals, Offsetting Positive News
Mar 12
▼
-1.0%
AbbVie (ABBV) dips slightly amid mixed signals, broader sector decline
Mar 11
▲
+0.3%
AbbVie (ABBV) modestly up on positive drug data
Mar 10
▼
-0.2%
AbbVie (ABBV) down slightly despite positive news
Mar 9
▼
-1.0%
AbbVie (ABBV) dips slightly despite positive drug data
Mar 6
▼
-1.0%
AbbVie (ABBV) Down Slightly Despite Positive News
Mar 5
▼
-1.7%
AbbVie (ABBV) dips slightly despite positive Skyrizi Crohn's data
Mar 4
▲
+0.9%
AbbVie (ABBV) Up Slightly on Positive Skyrizi Data, Manufacturing Expansion
Mar 3
▼
-0.2%
ABBV Down Slightly Despite Positive News
Mar 2
▲
+0.9%
AbbVie (ABBV) Climbs on Positive Crohn's Data, Outperforming Sector
Feb 27
▲
+3.1%
AbbVie (ABBV) Climbs on FDA Approval and Positive Outlook
Feb 26
▼
-1.0%
ABBV Declines Slightly Despite Positive News
Feb 25
▼
-0.6%
ABBV Down Slightly Despite Positive News; Market Weighs Valuation
Feb 24
▼
-0.4%
AbbVie (ABBV) dips slightly despite positive news
Feb 23
▲
+2.1%
AbbVie (ABBV) Climbs on FDA Approval, Dividend News
Feb 20
▲
+0.2%
AbbVie (ABBV) Up Slightly on FDA Approval, Dividend
Feb 19
▼
-1.7%
AbbVie (ABBV) dips amid mixed signals, declares dividend
Feb 18
▼
-1.8%
ABBV Declines Amidst Sector Weakness, Despite Strong Dividend
Highly Regarded Analysis for ABBV
Get a deep-dive analysis including bull/bear cases, technical outlook, price targets, and key catalysts — powered by Highly Regarded's proprietary analysis engine.
Usually takes 10-20 seconds
Analyzing ABBV...
Searching financial data and generating insights
Analysis couldn't be generated
Next Earnings
Date
Jul 30, 2026
Time
Before Open
Quarter
Q2 2026
EPS Estimate
$3.77
ABBV News
No recent news for ABBV.